I finished reading a very timely book on the exploding topic of artificial intelligence. Two very important reasons to read this book: 1) the author’s early work with GPT-4 and 2) the focus on medicine. A dominant conversation occurring in board rooms across the world involves the critical question of generative AI and its impact on a business and/or an industry. One of the authors is Peter Lee, Corporate VP for Research and Incubations at Microsoft. He leads the company’s worldwide research labs. For the past six years, his primary focus has been on AI’s uses in healthcare and the life sciences.